BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38458369)

  • 21. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chrysophanol-Induced Autophagy Disrupts Apoptosis via the PI3K/Akt/mTOR Pathway in Oral Squamous Cell Carcinoma Cells.
    Park DB; Park BS; Kang HM; Kim JH; Kim IR
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676666
    [No Abstract]   [Full Text] [Related]  

  • 23. Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma.
    Wang TH; Chen CC; Leu YL; Lee YS; Lian JH; Hsieh HL; Chen CY
    J Formos Med Assoc; 2021 Sep; 120(9):1695-1705. PubMed ID: 33342707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway.
    Wei M; Wu Y; Liu H; Xie C
    Drug Des Devel Ther; 2020; 14():395-405. PubMed ID: 32099325
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Sharif Siam MK; Sarker A; Sayeem MMS
    J Biomol Struct Dyn; 2021 Oct; 39(17):6467-6479. PubMed ID: 32746771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumol Exerts Antitumor Effect via Inhibiting EGFR-Akt-Mcl-1 Signaling.
    Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
    Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9
    Duan Y; Huang X; Qiao B; Ma R; Li J
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2799-2806. PubMed ID: 35331101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promotive effects of HOXA10 antisense RNA on the stemness of oral squamous cell carcinoma stem cells through a microRNA-29a/MCL-1/phosphatidyl inositol 3-kinase/protein kinase B axis.
    Wang D
    Arch Oral Biol; 2021 Jun; 126():105114. PubMed ID: 33831733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
    Long W; Gong X; Yang Y; Yang K
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ_0058063 Contributed to Oral Squamous Cell Carcinoma Development by Sponging miR-145 and Regulating PI3K/AKT Pathway.
    Zhou J; Jin S
    Mol Biotechnol; 2023 Dec; 65(12):2049-2060. PubMed ID: 36928742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway.
    Fan QC; Tian H; Wang Y; Liu XB
    Arch Oral Biol; 2019 May; 101():85-91. PubMed ID: 30909080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
    Li C; Lin XF; Wang JN; Ren XS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin nanoemulsions inhibit oral squamous cell carcinoma cell proliferation by PI3K/Akt/mTOR suppression and miR-199a upregulation: A preliminary study.
    Liu W; Wang J; Zhang C; Bao Z; Wu L
    Oral Dis; 2023 Nov; 29(8):3183-3192. PubMed ID: 35689522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A γ-Secretase Inhibitor Attenuates Cell Cycle Progression and Invasion in Human Oral Squamous Cell Carcinoma: An In Vitro Study.
    Pongjantarasatian S; Nowwarote N; Rotchanakitamnuai V; Srirodjanakul W; Saehun R; Janebodin K; Manokawinchoke J; Fournier BPJ; Osathanon T
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
    Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
    BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
    Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
    Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
    Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
    Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.